Pharmaceutical News

RSS

Computational approach to design peptide-based vaccine against SARS-Cov-2

There are currently no licensed vaccines available for COVID-19. While several antiviral drugs have been tested, none has proved to be completely effective against the disease.

11 Jun 2020

Study: Better data on marijuana use is needed to support critical public health research

Better data on marijuana use in the U.S. is needed to support critical public health research, according to a review of relevant surveys conducted by University of Massachusetts Amherst researchers.

11 Jun 2020

GlobalData: Use of hydroxychloroquine as COVID19 treatment continues to be debated

There is no clinical evidence that hydroxychloroquine is effective against COVID19. Some studies using hydroxychloroquine have shown no benefits or even an increase in risk of death, but the number of clinical trials investigating hydroxychloroquine as a primary or secondary intervention continues to expand to determine whether the drug candidate is a key contender as a therapeutic or not, says GlobalData, a leading data and analytics company.

10 Jun 2020

A drug to treat harsh complications of coronavirus infection is registered in Russia

Levilimab received state approval through a fast-track mechanism, according to Decree No. 441 of the Government of the Russian Federation of April 4, 2020, since its mechanism of action is associated with the control of the cytokine storm, which is one of the manifestations of coronavirus infection.

9 Jun 2020

Botox can be an effective treatment for certain sports injuries

While botulinum toxin is commonly known as a cosmetic treatment for facial lines and wrinkles, a growing body of evidence suggests that "Botox" can also be an effective treatment for certain sports injuries and chronic pain conditions, according to a review in the June issue of Current Sports Medicine Reports, official journal of the American College of Sports Medicine.

9 Jun 2020

Santen Pharmaceutical and jCyte conclude an exclusive licensing contract in Japan, Asia and Europe for the jCell therapy programme for retinitis pigmentosa

Santen Pharmaceutical Co., Ltd. and jCyte Inc. announced the conclusion of an exclusive licensing contract covering the development, registration and commercialisation rights in Japan, Asia and Europe to jCell, a first-in-class investigational therapy, currently in clinical development for retinitis pigmentosa.

From Santen Pharmaceutical Co., Ltd. 9 Jun 2020

Empagliflozin reduces CKD progression in type 2 diabetics with cardiovascular disease

Empagliflozin (EMPA), a selective inhibitor of sodium/glucose cotransporter 2 (SGLT2 inhibitors, "gliflozines"), reduces CKD progression in type 2 diabetics (T2D) with cardiovascular disease, presumably by lowering intraglomerular pressure.

9 Jun 2020

Scientists find way to prevent warmed-up vaccines from degrading

Vaccines are notoriously difficult to transport to remote or dangerous places, as they spoil when not refrigerated.

8 Jun 2020

New study highlights the credibility of registered clinical trials

In a time when we have to rely on clinical trials for COVID-19 drugs and vaccines, a new study in the Proceedings of the National Academy of Sciences of the United States of America (PNAS) brings good news about the credibility of registered clinical trials.

5 Jun 2020

Study highlights increased consumption of opioids in patients with osteoarthritis

Fentanyl, tramadol or tilidine: New European figures show that even in Europe increasingly more people are taking opioids for pain connected with rheumatic and musculoskeletal diseases.

5 Jun 2020

New report documents trends before the legalization of cannabis in Michigan

Nearly twelve years ago, Michigan voters approved the use of medical cannabis by residents with certain health conditions. A year and a half ago, they voted to approve its use by all adults, for any reason.

5 Jun 2020

New platform can speed up the development of novel antibiotics

Harmful bacteria react less and less to common antibiotics. The infections they cause are therefore increasingly deadly.

4 Jun 2020

Health care providers urged to stop hydroxycholoroquine use for COVID-19

The sacred oath taken by physicians during graduation from medical school to "First do no harm," the first words of the Hippocratic Oath, provides a strong impetus for a commentary just published in The American Journal of Medicine.

4 Jun 2020

Trastuzumab emtansine as a preferred second-line choice after horizontal dual blockade

Volume 11, Issue 22 of Oncotarget reported that despite relevant medical advancements, metastatic breast cancer remains an incurable disease.

3 Jun 2020

New drug can prevent life-threatening anaphylaxis, shows study

For someone with a food or drug allergy, the risk of life-threatening anaphylactic shock lurks around every corner. A new Northwestern Medicine study shows there might be a pill that can be taken proactively to prevent mild to life-threatening anaphylaxis, no matter the cause.

3 Jun 2020

Convalescent plasma therapy improves outcomes in majority of COVID-19 patients

First peer-reviewed publication on US trial results from Houston Methodist published in The American Journal of Pathology

3 Jun 2020

Study highlights the importance of child vaccine against infections

In the U.S., our children rarely fall ill to grave infections because they are protected by vaccines.

2 Jun 2020

Crucial ingredient from University of Kansas included in authorized COVID-19 drug

When the Food and Drug Administration issued an emergency-use authorization for the investigational pharmaceutical remdesivir to treat COVID-19 on May 1, in part it was due to pioneering work performed by pharmaceutical chemists at the University of Kansas School of Pharmacy in 1990.

1 Jun 2020

Study highlights potential benefits of new drug for inflammatory diseases

New research conducted by the University of Liverpool and AKL Research and Development Ltd, published in Inflammopharmacology, highlights the potential benefits of a new drug treatment on the human body's immune response in inflammation.

1 Jun 2020

Oral antidiabetics improve outcomes in diabetics with colorectal cancer

Bottom Line: Among patients with both colorectal cancer and diabetes in Korea, those who had a high adherence to their oral diabetes medication had a significantly reduced risk of overall mortality compared with those with lower adherence.

1 Jun 2020

Pharmaceutical News

Computational approach to design peptide-based vaccine against SARS-Cov-2

Study: Better data on marijuana use is needed to support critical public health research

GlobalData: Use of hydroxychloroquine as COVID19 treatment continues to be debated

A drug to treat harsh complications of coronavirus infection is registered in Russia

Botox can be an effective treatment for certain sports injuries

Santen Pharmaceutical and jCyte conclude an exclusive licensing contract in Japan, Asia and Europe for the jCell therapy programme for retinitis pigmentosa

Empagliflozin reduces CKD progression in type 2 diabetics with cardiovascular disease

Scientists find way to prevent warmed-up vaccines from degrading

New study highlights the credibility of registered clinical trials

Study highlights increased consumption of opioids in patients with osteoarthritis

New report documents trends before the legalization of cannabis in Michigan

New platform can speed up the development of novel antibiotics

Health care providers urged to stop hydroxycholoroquine use for COVID-19

Trastuzumab emtansine as a preferred second-line choice after horizontal dual blockade

New drug can prevent life-threatening anaphylaxis, shows study

Convalescent plasma therapy improves outcomes in majority of COVID-19 patients

Study highlights the importance of child vaccine against infections

Crucial ingredient from University of Kansas included in authorized COVID-19 drug

Study highlights potential benefits of new drug for inflammatory diseases

Oral antidiabetics improve outcomes in diabetics with colorectal cancer

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Latest News